I-Cholesterol ephezulu kunye nesifo sikashukela Ngaba I-Recipe ye-Heart Heart
Iingcali zenzululwazi zifumana ubungqina bokuba isifo sikashukela ngokwawo siphumeza umonakalo nge- cholesterol , okwandisa kakhulu amathuba okuhlaselwa yintliziyo okanye ukuhlaselwa kwesifo . Ubuhlobo obusondeleyo phakathi kwezi zimbini zengozi kuthetha ukuba ukuba unesifo sikashukela, kufuneka uqaphele kakhulu ngokulawula i-cholesterol yakho.
Isixhumanisi Phakathi kwe-Insulin kunye neCholesterol
Abaphandi basacinga ngokucacileyo ukuba isifo sikashukela sitshintsha njani ama-cholesterol amanqanaba kwinqanaba lamaseli amancinci.
Bayazi ukuba amazinga aphakamileyo e-insulin egazini athambekele ekuthinteleleni inani leengqungquthela ze-cholesterol egazini.
Amanqanaba aphezulu e-insulin asebenza ukuphakamisa inani le-LDL-cholesterol ("i-cholesterol embi") edla ukuba yenze iiplates kwiimitha ze-arridi kwaye inciphise inani le- HDL ye- cholesterol inxenye ("i-cholesterol efanelekileyo") enceda ukucima iipliti eziyingozi ngaphambi kokuba ziphule ukukhupha intliziyo okanye ukubetha. Isifo sikashukela sinokubangela ukuba amazinga aphezulu e- triglycerides , olunye uhlobo lweoli ejikeleza egazini.
Ngokufanayo, i-cholesterol ephezulu ingakhokelela kwisifo sikashukela; Amanqanaba e-cholesterol ephakamileyo aqheleke kubonakala kubantu abanoxinzelelo lwe-insulin, nangaphambi kokuba bavelise isifo sikashukela esipheleleyo. Xa amazinga e-LDL aqala ukunyuka, iingcali zincoma ukubeka ingqwalasela ngokufutshane ekulawuleni ushukela wegazi nokuqala ukutya nokusebenzisa imodemu yokuncedisa ukukhusela isifo sikashukela nesifo senhliziyo.
Oku kubaluleke ngakumbi ukuba unentsapho yentsapho yesifo senhliziyo.
Kubantu abanesifo sikashukela se-Type 1 , ukulawula iswekile yegazi kungenza umehluko omkhulu. Ukulawulwa kakuhle kweshukela kwegazi kuhambelana nemilinganiselo ye-cholesterol esondeleyo, efana neyabonwa kubantu abangenayo i-diabetes. Kodwa abantu abane-diabetes yohlobo lwe-1 abanokungalawulwa kakubi, banyuse amanqanaba e-triglyceride kunye namazinga angaphantsi kwe-HDL, okufaka isandla ekuphuhlisweni kwemibhobho eminyango.
Uhlobo lweSibini lwesifo sikashukela: Umngcipheko ophezulu ngokukodwa kwi-High Cholesterol
Abantu abane- Type 2 yeswekile , kungakhathaliseki ukulawulwa kweshukela kwegazi, bathambekele ekunyuseni i-triglycerides , behla i-HDL, kwaye ngamanye amaxesha banda i-LDL. Le projekthi ye-cholesterol ingaphikelela nangona iqondo leetyhukela legazi liphantsi kolawulo-olubhekiselele kwimeko ephakamileyo ngakumbi yokuphuhlisa iiplathi. Enyanisweni, iiplanga ezakhiwe kwimibhobho yabantu abane-Type 2 isifo sikashukela zidla ngokugqithiseleyo kwaye zingaphantsi kunezifo ezinesifo sikashukela, ezikhokelela kumngcipheko ophezulu ngakumbi weplate ekhuphayo ukuze ibangele intliziyo okanye isifo.
Umbutho we-American Diabetes Association uncoma ukuba ukhangele i-cholesterol amazinga ubuncinane kanye ngonyaka, okanye ngaphezulu ukuba ngaba aphezulu kwaye alawulwa ngamachiza. Kubantu abanesifo sikashukela kunye nesifo senhliziyo esaziwayo, kuyacetyiswa ukuba amazinga e-LDL egazini abe ngaphantsi kwama-milligram e-deciliter (mg / dL), ukuba amazinga e-HDL abe ngaphezu kwe-50 mg / dL, kwaye i-triglycerides engaphantsi kwe-150 mg / dL. Isetyhu ephakanyisiweyo yegazi, okanye i-glucose, inqanaba lingaphantsi kwe-7% (<7%) kwi-HA1C.
Kubantu abanesifo sikashukela kunye nesifo senhliziyo yesifo se-coronary, kubandakanywa iirriji ezivaliweyo okanye ukuhlaselwa kwangaphambili kwintliziyo, i-ADA ikhuthaza i-LDL ngaphantsi kwe-70 mg / dL.
Ukufikelela kule nqophiso ephantsi kakhulu ye-LDL kungadinga ukunyuka kwamayeza e-statin, kodwa kuboniswa ukuba kunciphise kakhulu umngcipheko wokuhlaselwa kwentliziyo. Amanqanaba e-Triglyceride kufuneka abe ngaphantsi kwe-150 mg / dL kunye ne-HDL ngaphezulu kwe-40 mg / dL. Abasetyhini abanesifo sikashukela kunye nesifo sengqondo senhliziyo esele sikhona banconywa ukuba babe namazinga e-HDL ngaphezulu kwe-50 mg / dL.
Elinye iyeza, i- WelChol (colesevelam), iboniswe ukuba isinciphise kokubili i-glucose kunye namazinga e-cholesterol kubantu abane-Type 2 yeswekile. I-Welchol isenzo ngokuthintela amathumbu ukuba athathe ama-molecule athile ekudleni. Nangona i-Welchol inamanqanaba angaphantsi kwe- LDL , ingakwazi ukuphakamisa amanqanaba e-triglyceride egazini, kwaye ayifanele isetyenziswe ngabantu abane-triglycerides ephezulu.
I-Metabolic Syndrome kunye neCholesterol
Abantu abanesiphako seengxaki ezifana nokunyanzelwa kwe-insulin, amazinga e-cholesterol ahluphekileyo, uxinzelelo lwegazi oluphezulu kunye nokukhuluphala kuboniswe njengesixinzelelo sesifo segazi (esaziwa ngokuba yi-syndrome X). Izifundo ziye zafumanisa ukuba izigulane ezine-HDL ephantsi kunye ne-triglycerides ephezulu-eziphawulekayo zesifo se-metabolic - zinobungozi obukhulu bokuhlaselwa kwesifo senhliziyo okanye isifo. Abantu abaneprofayili ye-cholesterol banceda kakhulu kuninzi kwimithi yamayeza.
Imingcipheko eyahlukeneyo yesifo senhliziyo ivela kwisandla kwaye kufuneka iphathwe kunye. Abantu abanesifo sikashukela - abanomngcipheko ophezulu wolu suku oluneentlungu zentliziyo - kufuneka baqaphele ngokugcina iswayi segazi kunye ne-cholesterol kumanqanaba aphantsi. Kwakhona kubalulekile ukugcina ubunzima obunempilo kunye noxinzelelo lwegazi oluphantsi kunye nokuphepha ukutshaya.
Imithombo:
Umbutho weSwekile waseMelika. "I-ADA I-Statement Statement: Imigangatho yoLondolozo lwezoNyango kwiSwekile." Ukunyamekela ngesifo sikashukela 30 (2007): I-Suppl 1.
UMcCulloch, uDavid K. "Inkcazo yoLondolozo lwezoNyango kubantu abadala abaneSifo soSwekile iMellitus." UpToDate.com. 2008. UpToDate. 6 kuMatshi 2008. (ubhaliso)
Meigs, James B. "I-Metabolic Syndrome (i-insulin Resistance Syndrome okanye i-Syndrome X)." UpToDate.com. 2008. UpToDate. 7 kuMeyi 2008. (ubhaliso)
U-Nesto, uRichard W. "Ubuninzi bezinto ezinobungozi beCoronary Heart disease kwiSifo sikashukela iMellitus." UpToDate.com. 2008. UpToDate. 6 kuMatshi 2008. (ubhaliso)
Pyorala, K., et al. "Ukunciphisa iMicimbi ye-Cardiovascular by Simvastatin kwi-Nondiabetic Coronary Heart Disease Izigulane ezingenawo ngaphandle kweMetabolic Syndrome: Uhlalutyo lweScandinavian Simvastatin Survival Study (4S)." Uncedo lweSwekile 27 (2004): 1735-40.
URosenson, uRobert S. "Uqheliso lweNyango ye-Hypercholesterolemia." UpToDate.com. 2008. UpToDate. 30 Mar2008 (ukubhalisa)
URosenson, uRobert S. "Izizathu eziSondlo zeDyslipidemia." UpToDate.com. 2008. UpToDate. 26 Matshi 2008. (ubhaliso)
INgxelo yesithathu yeNkqubo yeMfundo yeSizwe yeCholesterol (NCEP) iPhaneli yeNzululwazi ekuThekeni, kuVavanyo kunye nokuPhathwa kwe-High Blood Cholesterol kuBantu abadala (i-Panel Treatment Panel III). Ukujikeleza 106 (2002): 3143.
Zieve, FJ, MF Kalin, SL Schewartz, MR Jones, kunye noWL Bailey. "Iziphumo ze-Glucose-Impembelelo yokunciphisa i-WelChol Study (GLOWS): Isifundo soPhando oluPhezulu oluLungeleleneyo, oluPhindwe kabini, oluPhezulu lwePawebo. Ukuhlola umphumo weColesevelam Hydrochloride kwi-Glycemic Control in Subjects nge Type 2 Diabetes. Iingcali zokwelapha 29 (2007): 74-83.